Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA448516
Max Phase: Preclinical
Molecular Formula: C36H64N7O17P3S
Molecular Weight: 991.93
Molecule Type: Small molecule
Associated Items:
ID: ALA448516
Max Phase: Preclinical
Molecular Formula: C36H64N7O17P3S
Molecular Weight: 991.93
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCCCCCCCCCCC(=O)CSCCNC(=O)CCNC(=O)C(O)C(C)(C)COP(=O)(O)OP(=O)(O)OC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1OP(=O)(O)O
Standard InChI: InChI=1S/C36H64N7O17P3S/c1-4-5-6-7-8-9-10-11-12-13-14-15-25(44)21-64-19-18-38-27(45)16-17-39-34(48)31(47)36(2,3)22-57-63(54,55)60-62(52,53)56-20-26-30(59-61(49,50)51)29(46)35(58-26)43-24-42-28-32(37)40-23-41-33(28)43/h23-24,26,29-31,35,46-47H,4-22H2,1-3H3,(H,38,45)(H,39,48)(H,52,53)(H,54,55)(H2,37,40,41)(H2,49,50,51)/t26-,29-,30-,31?,35-/m1/s1
Standard InChI Key: JKWHUJMJVNMKEF-DJEJIMQCSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 991.93 | Molecular Weight (Monoisotopic): 991.3292 | AlogP: 3.41 | #Rotatable Bonds: 33 |
Polar Surface Area: 363.63 | Molecular Species: ACID | HBA: 19 | HBD: 9 |
#RO5 Violations: 3 | HBA (Lipinski): 24 | HBD (Lipinski): 10 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 0.82 | CX Basic pKa: 4.84 | CX LogP: -0.43 | CX LogD: -6.51 |
Aromatic Rings: 2 | Heavy Atoms: 64 | QED Weighted: 0.04 | Np Likeness Score: 0.44 |
1. Paige LA, Zheng GQ, DeFrees SA, Cassady JM, Geahlen RL.. (1989) S-(2-oxopentadecyl)-CoA, a nonhydrolyzable analogue of myristoyl-CoA, is a potent inhibitor of myristoyl-CoA:protein N-myristoyltransferase., 32 (8): [PMID:2754690] [10.1021/jm00128a001] |
2. Wu J, Tao Y, Zhang M, Howard MH, Gutteridge S, Ding J.. (2007) Crystal structures of Saccharomyces cerevisiae N-myristoyltransferase with bound myristoyl-CoA and inhibitors reveal the functional roles of the N-terminal region., 282 (30): [PMID:17513302] [10.1074/jbc.m702696200] |
Source(1):